YOU ARE HERE: LAT HomeCollectionsDiabetes


December 11, 2012 | By Eryn Brown
An increase in vision problems that cannot be corrected with lenses may be related to an uptick in diabetes rates over the same period, researchers said Tuesday. The team, led by Dr. David S. Friedman of the Johns Hopkins University School of Medicine in Baltimore, gathered survey and physical examination data collected from 9,471 U.S. adults over the age of 20 in 1999 to 2002 and from another set of 10,480 Americans in 2005 to 2008.  The researchers calculated that rates of prevalence of “non-refractive visual impairment” increased 21% in the overall study population, from 1.4% in 1999-2002 to 1.7% in 2005-2008.
December 5, 2012 | By Melissa Healy, Los Angeles Times, For the Booster Shots Blog
The robust good health of newly arrived Mexican immigrants is an article of faith among public health experts--as is the notion that the longer they are in the United States, the unhealthier they become. But the idea that emigrating to the United States is bad for a newcomer's health--possibly because he departs from the healthful eating and exercise habits of his home country--has a major flaw in it, a new study says: These immigrants may not be so healthy to begin with. They just don't know it--yet.
November 27, 2012 | By Mary MacVean
Researchers from USC and the University of Oxford say they have found an association between countries that have more high fructose corn syrup in their food supply and those that have higher rates of diabetes. Countries with higher use of HFCS had an average prevalence of Type 2 diabetes of 8%, compared with 6.7% in countries that don't use it, according to the research published Tuesday in the journal Global Public Health. Those differences held, the researchers said, after adjustments for body mass index, population and gross domestic product.
November 16, 2012 | By Eryn Brown, Los Angeles Times
Diabetes prevalence rates jumped dramatically across the nation between 1995 and 2010, researchers at the U.S. Centers for Disease Control reported in Friday's edition of the Morbidity and Mortality Weekly Report . Using data from the Behavioral Risk Factor Surveillance System, an annual phone survey of adults 18 and older, the investigators found that overall, the median prevalence of diagnosed diabetes went up from 4.5% in 1995 to 8.2% in...
September 26, 2012 | By Rosie Mestel
There's a lot of talk these days about the role of gut bacteria in disease and health. The latest report in that area: a study in Nature that finds differences between the bacteria growing in the guts of people who have diabetes and those who don't. The Chinese and European authors of the study used DNA analysis to figure out the bacterial populations inside 345 Chinese people. They found that people with diabetes had mild gut disturbances. They had fewer bacteria that make a compound called butyrate, for example.
August 8, 2012 | By Melissa Healy, Los Angeles Times
Against the drumbeat of bad news on obesity and diabetes among children, researchers have uncovered a cause for cautious optimism: a steady and significant improvement in the cholesterol profiles of American kids over the last 20 years. The proportion of young people ages 6 to 19 with high total cholesterol dropped 28% between the two time periods sampled in the report, from 11.3% in 1988-94 down to 8.1% in 2007-10, the new study found. At the same time, the average American teen's levels of "good" HDL cholesterol, "bad" LDL cholesterol and triglycerides - dangerous fats that circulate in the bloodstream and slowly clog arteries - improved too. Scientists said they weren't sure what had led to the encouraging changes reported Tuesday in the Journal of the American Medical Assn.Use of cholesterol-lowering drugs remains rare among children, they noted.
June 30, 2012 | Bloomberg News
Amylin Pharmaceuticals Inc., the San Diego drug maker whose treatments include the diabetes therapies Bydureon and Byetta, will be acquired by Bristol-Myers Squibb Co. for $5.3 billion in cash. Bristol-Myers agreed to pay $31 a share for Amylin, the companies said Friday in a statement. That's 10% more than the company's closing price Friday. Including Amylin's debt and a payment to Eli Lilly & Co. of about $1.7 billion, the deal is valued at about $7 billion. "We are pleased to be able to strengthen the portfolio we have built to help patients with diabetes by building on the success Amylin has had with its GLP-1 franchise," said Bristol-Myers Chief Executive Lamberto Andreotti in the statement.
June 20, 2012 | By Rosie Mestel, Los Angeles Times / For the Booster Shots blog
After gastric bypass surgery, people with  Type 2 diabetes often see their disease completely  disappear  - within weeks, before they've lost much or any weight. It doesn't work for everyone, though.  What are the factors that matter? A study by a team of scientists from the University of Massachussetts looked into that. Here are their findings, which were presented at the annual meeting of the American Society for Metabolic and Bariatric Surgery. The scientists looked at remission of diabetes in 139 patients, ages 48 to 57, who'd had gastric bypass surgery.
June 18, 2012 | By John Hoeffel, Los Angeles Times
Randy Muñoz glided among the guests, greeting and hugging them. They were in a posh club 54 floors above Los Angeles, and the windows looked out to a shimmering vista of lighted streets. They swirled cocktails, dined on shrimp and gyoza, soaked up a Latin trio and traded pleasantries. Then Muñoz, called on to speak, riled the serenity with a jolt of emotion. "How many of you guys have diabetes in your families? OK. Keep those hands up and look around. Look around. That's disgusting.
June 13, 2012 | By Tiffany Hsu
Paula Deen may be bringing more of her butter-drenched recipes to supermarkets and retailers such as Target, Wal-Mart and Kroger with the creation of her new Paula Deen Foods company. Think classic Deen creations "as well as lighter versions," according to a news release this week about the launch. The products are expected to hit shelves this fall. The Georgia-based celebrity chef is pairing up with Buffalo, N.Y.-based Nanco Group, which launched and sold Tops Friendly Markets and Wilson Farms Stores under the ownership of the Nanula family, to develop products and run quality control.
Los Angeles Times Articles